Clinical Trial Update: Standard Versus High Dose ED-Initiated Buprenorphine Induction [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing standard-dose versus high-dose ED-initiated buprenorphine induction for opioid use disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: Opioid Use Disorder | Phase 3 | Status: RECRUITING